Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA604950
Max Phase: Preclinical
Molecular Formula: C25H32Cl2N2O3
Molecular Weight: 479.45
Molecule Type: Small molecule
Associated Items:
ID: ALA604950
Max Phase: Preclinical
Molecular Formula: C25H32Cl2N2O3
Molecular Weight: 479.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCNC(=O)Oc1ccc(Cl)cc1C(=O)Nc1cccc(Cl)c1
Standard InChI: InChI=1S/C25H32Cl2N2O3/c1-2-3-4-5-6-7-8-9-10-16-28-25(31)32-23-15-14-20(27)18-22(23)24(30)29-21-13-11-12-19(26)17-21/h11-15,17-18H,2-10,16H2,1H3,(H,28,31)(H,29,30)
Standard InChI Key: KSLNYHMTVGDCND-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 479.45 | Molecular Weight (Monoisotopic): 478.1790 | AlogP: 7.86 | #Rotatable Bonds: 13 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.96 | CX Basic pKa: | CX LogP: 8.21 | CX LogD: 8.21 |
Aromatic Rings: 2 | Heavy Atoms: 32 | QED Weighted: 0.29 | Np Likeness Score: -1.08 |
1. Férriz JM, Vávrová K, Kunc F, Imramovský A, Stolaríková J, Vavríková E, Vinsová J.. (2010) Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains., 18 (3): [PMID:20060303] [10.1016/j.bmc.2009.12.055] |
2. Imramovsky A, Pesko M, Ferriz JM, Kralova K, Vinsova J, Jampilek J.. (2011) Photosynthesis-Inhibiting efficiency of 4-chloro-2-(chlorophenylcarbamoyl)phenyl alkylcarbamates., 21 (15): [PMID:21724391] [10.1016/j.bmcl.2011.05.118] |
Source(1):